Created in 2003 (United States), SOSTEGRA own
126 sister brands
and 17478 competing brands.
SOSTEGRA is owned by Celgene, listed on the stock exchange of New York
SOSTEGRA is part of the Drug Manufacturers activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.